Latest Breaking News On - Monique allaire - Page 1 : vimarsana.com

Avalyn to Participate in Jefferies Global Healthcare Conference

Avalyn to Participate in Jefferies Global Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesAvalyn pharmaMonique allaireMarriott marquisStrategic communicationsAvalyn pharma incJefferies global healthcarePharma incYork marriott marquis

Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imaging Biomarker Data, at ATS 2024

Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imaging Biomarker Data, at ATS 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomSan diegoUnited statesAvalyn pharmaMonique allaireHowardm lazarusInternational conferenceAmerican thoracic societyStrategic communicationsAvalyn pharma incPresents clinical dataPulmonary fibrosisIncluding long term efficacyImaging biomarker dataInhaled pirfenidoneTolerability out

Auron Unveils Preclinical Data Supporting its Lead Program and Ability of its AURIGIN™ Platform to Generate Targeted Cancer Therapies at AACR Annual Meeting

Auron Unveils Preclinical Data Supporting its Lead Program and Ability of its AURIGIN™ Platform to Generate Targeted Cancer Therapies at AACR Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesRoss levineMonique allaireStrategic communicationsTranslational research at memorial sloan ketteringAmerican association for cancer researchUnveils preclinical data supportingLead programGenerate targeted cancer therapiesAmerican associationCancer researchKate yenChief executive officerSenior vice presidentTranslational researchMemorial sloan

Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement

ANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024;

San franciscoUnited statesSheryl seapyMonique allaireStrategic communicationsSecurities exchangeAnnexon incGlobal pivotal program in geographic atrophyGlobal registration programFirst halfFirst approved treatmentPivotal programGeographic atrophyPivotal trial using vision preservationPrimary outcome measureProof of concept study

Annexon Outlines 2024 Priorities with Late-Stage Clinical

ANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024;Potential to be First Approved Treatment for GBS Patients in.

San franciscoUnited statesMonique allaireSheryl seapyStrategic communicationsAnnexon incSecurities exchangeGlobal registration programGlobal pivotal program in geographic atrophyFirst halfFirst approved treatmentPivotal programGeographic atrophyPivotal trial using vision preservationPrimary outcome measureProof of concept study